Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Liver Transplantation

  Free Subscription

Articles published in Transpl Int

Retrieve available abstracts of 162 articles:
HTML format

Single Articles

    January 2024
  1. LOMBARDI A, Alagna L, Palomba E, Viero G, et al
    New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties.
    Transpl Int. 2024;37:11692.
    PubMed     Abstract available

  2. VANLERBERGHE BTK, van Malenstein H, Sainz-Barriga M, Jochmans I, et al
    Tacrolimus Drug Exposure Level and Smoking Are Modifiable Risk Factors for Early De Novo Malignancy After Liver Transplantation for Alcohol-Related Liver Disease.
    Transpl Int. 2024;37:12055.
    PubMed     Abstract available

  3. KANG M, Koh HH, Kim DG, Yim SH, et al
    Clinical Impact and Risk Factors of Seizure After Liver Transplantation: A Nested Case-Control Study.
    Transpl Int. 2024;37:12342.
    PubMed     Abstract available

  4. MESZAROS AT, Weissenbacher A, Schartner M, Egelseer-Bruendl T, et al
    The Predictive Value of Graft Viability and Bioenergetics Testing Towards the Outcome in Liver Transplantation.
    Transpl Int. 2024;37:12380.
    PubMed     Abstract available

  5. O'CALLAGHAN JM, Fallon J
    Transplant Trial Watch.
    Transpl Int. 2024;37:12853.

  6. BELGHITI J, Cauchy F, Antoine C, Cheron G, et al
    Solid Organ Transplant Litigation at One of Europe's Largest University Hospitals.
    Transpl Int. 2024;37:12439.
    PubMed     Abstract available

  7. TEJEDOR M, Neria F, De La Rosa G, Almohalla Alvarez C, et al
    Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry.
    Transpl Int. 2024;37:12732.
    PubMed     Abstract available

  8. HOFMANN J, Kofler A, Schartner M, Buch ML, et al
    Assessment of Mitochondrial Respiration During Hypothermic Storage of Liver Biopsies Following Normothermic Machine Perfusion.
    Transpl Int. 2024;37:12787.
    PubMed     Abstract available

  9. RASTOGI A, Gupta AA, Bansal R, Kollanta Valappil F, et al
    Minimizing Incision in Living Donor Liver Transplantation: Initial Experience and Comparative Analysis of Upper Midline Incision in 115 Recipients.
    Transpl Int. 2024;37:12536.
    PubMed     Abstract available

  10. CHOTKAN KA, Alwayn IPJ, Hemke AC, Baranski A, et al
    Ten Years of Quality Monitoring of Abdominal Organ Procurement in the Netherlands and Its Impact on Transplant Outcome.
    Transpl Int. 2024;37:12989.
    PubMed     Abstract available

  11. ROSSIGNOL G, Muller X, Ruiz M, Collardeau-Frachon S, et al
    HOPE Mitigates Ischemia-Reperfusion Injury in Ex-Situ Split Grafts: A Comparative Study With Living Donation in Pediatric Liver Transplantation.
    Transpl Int. 2024;37:12686.
    PubMed     Abstract available

    January 2023
  12. KO D, Ridner SH, Gifford KA
    Subjective Cognition is Related to Patient-Reported Symptom Distress and Work Productivity Among Liver Transplant Recipients.
    Transpl Int. 2023;36:10863.
    PubMed     Abstract available

  13. STRINGA P, Vecchio Dezillio LE, Talayero P, Serradilla J, et al
    Experimental Assessment of Intestinal Damage in Controlled Donation After Circulatory Death for Visceral Transplantation.
    Transpl Int. 2023;36:10803.
    PubMed     Abstract available

  14. ZENG J, Li Q, Wu Q, Li L, et al
    A Novel Online Calculator Predicting Acute Kidney Injury After Liver Transplantation: A Retrospective Study.
    Transpl Int. 2023;36:10887.
    PubMed     Abstract available

  15. CORTESI PA, Vigano R, Conti S, Lenci I, et al
    Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.
    Transpl Int. 2023;36:10954.
    PubMed     Abstract available

  16. KRENDL FJ, Fodor M, Messner F, Balog A, et al
    Liver Transplantation in Recipients With a Positive Crossmatch: A Retrospective Single-Center Match-Pair Analysis.
    Transpl Int. 2023;36:11062.
    PubMed     Abstract available

  17. MUHAMMAD I, Rehman FUL, Wang F, Xiong X, et al
    Application Effectiveness of Segment IV Portal Vein Reconstruction for Early Postoperative Liver Function Recovery in Split Liver Transplantation.
    Transpl Int. 2023;36:10808.
    PubMed     Abstract available

  18. ANDACOGLU O, Izzy M, Adelmann D, Aguilera V, et al
    Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.
    Transpl Int. 2023;36:11240.
    PubMed     Abstract available

  19. SEBAGH M, Yilmaz F, Kounis I, Saliba F, et al
    Evidence for Alloimmune Sinusoidal Injury in De Novo Nodular Regenerative Hyperplasia After Liver Transplantation.
    Transpl Int. 2023;36:11306.
    PubMed     Abstract available

  20. GROSSI AA, Puoti F, Masiero L, Troni A, et al
    Inequities in Organ Donation and Transplantation Among Immigrant Populations in Italy: A Narrative Review of Evidence, Gaps in Research and Potential Areas for Intervention.
    Transpl Int. 2023;36:11216.
    PubMed     Abstract available

  21. FALLANI G, Stocco A, Siniscalchi A, Antonini MV, et al
    Beyond the Concepts of Elder and Marginal in DCD Liver Transplantation: A Prospective Observational Matched-Cohort Study in the Italian Clinical Setting.
    Transpl Int. 2023;36:11697.
    PubMed     Abstract available

  22. QAZI ARISAR FA, Salinas-Miranda E, Ale Ali H, Lajkosz K, et al
    Development of a Radiomics-Based Model to Predict Graft Fibrosis in Liver Transplant Recipients: A Pilot Study.
    Transpl Int. 2023;36:11149.
    PubMed     Abstract available

  23. BERENGUER M, de Martin E, Hessheimer AJ, Levitsky J, et al
    European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.
    Transpl Int. 2023;36:11358.
    PubMed     Abstract available

  24. OLANDER AE, Helenius-Hietala J, Nordin A, Savikko J, et al
    Association Between Pre-Transplant Oral Health and Post-Liver Transplant Complications.
    Transpl Int. 2023;36:11534.
    PubMed     Abstract available

  25. CLAASEN MPAW, Sneiders D, Rakke YS, Adam R, et al
    European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma.
    Transpl Int. 2023;36:11648.
    PubMed     Abstract available

  26. CARBONE M, Della Penna A, Mazzarelli C, De Martin E, et al
    Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus Statement.
    Transpl Int. 2023;36:11729.
    PubMed     Abstract available

  27. VIANNA R, Gaynor JJ, Selvaggi G, Farag A, et al
    Liver Inclusion Appears to Be Protective Against Graft Loss-Due-to Chronic But Not Acute Rejection Following Intestinal Transplantation.
    Transpl Int. 2023;36:11568.
    PubMed     Abstract available

  28. GIORGAKIS E, Estrada MM, Wells A, Garcia Saenz de Sicilia M, et al
    Women Referred for Liver Transplant Are Less Likely to Be Transplanted Irrespective of Socioeconomic Status.
    Transpl Int. 2023;36:11667.

  29. MINCIUNA I, den Hoed C, van der Meer AJ, Sonneveld MJ, et al
    The Yield of Routine Post-Operative Doppler Ultrasound to Detect Early Post-Liver Transplantation Vascular Complications.
    Transpl Int. 2023;36:11611.
    PubMed     Abstract available

  30. CARBONE M, Neuberger J, Rowe I, Polak WG, et al
    European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care.
    Transpl Int. 2024;36:12190.
    PubMed     Abstract available

    January 2022
  31. LEE CY, Wu MY, Chan HC, Chen TT, et al
    The Influence of Diabetes Mellitus on the Risks of End-Stage Kidney Disease and Mortality After Liver Transplantation.
    Transpl Int. 2022;36:10023.
    PubMed     Abstract available

  32. SANADA Y, Sakuma Y, Onishi Y, Okada N, et al
    Hepatolithiasis After Living Donor Liver Transplantation in Pediatric Patients: Mechanism, Diagnosis, Treatment, and Prognosis.
    Transpl Int. 2022;36:10220.
    PubMed     Abstract available

  33. DALZELL C, Vargas PA, Soltys K, Dipaola F, et al
    Living Donor Liver Transplantation vs. Split Liver Transplantation Using Left Lateral Segment Grafts in Pediatric Recipients: An Analysis of the UNOS Database.
    Transpl Int. 2022;36:10437.
    PubMed     Abstract available

  34. KITANO Y, Pietrasz D, Fernandez-Sevilla E, Golse N, et al
    Subjective Difficulty Scale in Liver Transplantation: A Prospective Observational Study.
    Transpl Int. 2022;35:10308.
    PubMed     Abstract available

  35. SAKAI A, Morishita T, Matsunami H
    Antibody Response After a Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Liver Transplant Recipients.
    Transpl Int. 2022;35:10321.

  36. FRIEND P, Pollok JM
    Hypothermic Machine Perfusion in Liver Transplantation-A Randomised Trial and Beyond.
    Transpl Int. 2022;35:10257.

  37. HERRERO A, Boivineau L, Cassese G, Assenat E, et al
    Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular Carcinoma.
    Transpl Int. 2022;35:10412.
    PubMed     Abstract available

  38. BECKMANN S, Kunzler-Heule P, Kabut K, Mauthner O, et al
    The Main Thing is to be Alive-Exploring Patients' Experiences With Weight Gain After Liver Transplantation: A Qualitative Study.
    Transpl Int. 2022;35:10256.
    PubMed     Abstract available

  39. NEDKOVA-HRISTOVA V, Baliellas C, Gonzalez-Costello J, Llado L, et al
    Treatment With Diflunisal in Domino Liver Transplant Recipients With Acquired Amyloid Neuropathy.
    Transpl Int. 2022;35:10454.
    PubMed     Abstract available

  40. SEEHOFER D, Petrowsky H, Schneeberger S, Vibert E, et al
    Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation-Adjusting the Odds?
    Transpl Int. 2022;35:10333.
    PubMed     Abstract available

  41. KIM MS, Hong SK, Woo HY, Cho JH, et al
    Optimal Intervention for Initial Treatment of Anastomotic Biliary Complications After Right Lobe Living Donor Liver Transplantation.
    Transpl Int. 2022;35:10044.
    PubMed     Abstract available

  42. CUK N, Melamed KH, Vangala S, Salah R, et al
    Postoperative Trapped Lung After Orthotopic Liver Transplantation is a Predictor of Increased Mortality.
    Transpl Int. 2022;35:10387.
    PubMed     Abstract available

  43. YAMAGUCHI N, Matsuyama R, Kikuchi Y, Sato S, et al
    Role of the Intramural Vascular Network of the Extrahepatic Bile Duct for the Blood Circulation in the Recipient Extrahepatic Bile Duct Used for Duct-to-Duct-Biliary-Anastomosis in Living Donor Liver Transplantation.
    Transpl Int. 2022;35:10276.
    PubMed     Abstract available

  44. SCHULZ MS, Gu W, Schnitzbauer AA, Trebicka J, et al
    Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure.
    Transpl Int. 2022;35:10108.
    PubMed     Abstract available

  45. SERRANO MT, Sabroso S, Esteban LM, Berenguer M, et al
    Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort.
    Transpl Int. 2022;35:10263.
    PubMed     Abstract available

  46. DE SIMONE P, Ghinolfi D
    Hospital-Based Health Technology Assessment of Machine Perfusion Systems for Human Liver Transplantation.
    Transpl Int. 2022;35:10405.
    PubMed     Abstract available

  47. HUNT F, Johnston CJC, Coutts L, Sherif AE, et al
    From Haphazard to a Sustainable Normothermic Regional Perfusion Service: A Blueprint for the Introduction of Novel Perfusion Technologies.
    Transpl Int. 2022;35:10493.
    PubMed     Abstract available

  48. GEORGES P, Clerc C, Turco C, Di Martino V, et al
    Post-Transplantation Cytomegalovirus Infection Interplays With the Development of Anastomotic Biliary Strictures After Liver Transplantation.
    Transpl Int. 2022;35:10292.
    PubMed     Abstract available

  49. HANN A, Nutu A, Clarke G, Patel I, et al
    Normothermic Machine Perfusion-Improving the Supply of Transplantable Livers for High-Risk Recipients.
    Transpl Int. 2022;35:10460.
    PubMed     Abstract available

  50. DINGFELDER J, Rauter L, Berlakovich GA, Kollmann D, et al
    Biliary Viability Assessment and Treatment Options of Biliary Injury During Normothermic Liver Perfusion-A Systematic Review.
    Transpl Int. 2022;35:10398.
    PubMed     Abstract available

  51. SMEDMAN TM, Guren TK, Tveit KM, Thomsen M, et al
    Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy.
    Transpl Int. 2022;35:10404.
    PubMed     Abstract available

  52. AGUILERA I, Sousa JM
    Comments on: Differential IgG4-Producing Plasma Cell Infiltration in Non- and Post-Transplant Plasma Cell Hepatitis.
    Transpl Int. 2022;35:10590.

  53. AGUILERA V, Andacoglu O, Francoz C, Berlakovich G, et al
    Gender and Racial Disparity Among Liver Transplantation Professionals: Report of a Global Survey.
    Transpl Int. 2022;35:10506.
    PubMed     Abstract available

  54. SHIMADA S, Shamaa T, Ivanics T, Kitajima T, et al
    Liver Transplant Recipient Characteristics Associated With Worse Post-Transplant Outcomes in Using Elderly Donors.
    Transpl Int. 2022;35:10489.
    PubMed     Abstract available

  55. ZHOU GP, Wei L, Zhu ZJ
    Adopting Individualized Strategies to Prevent Large-For-Size Syndrome in Adult Liver Transplant Recipients: The Graft Morphology Should Also Be Taken Into Account.
    Transpl Int. 2022;35:10683.

  56. HE D, Pu X, Jiang L
    How to Choose the Optimal Surgical Strategy to Predict and Prevent LFSS Following Liver Transplantation?
    Transpl Int. 2022;35:10805.

  57. EEROLA V, Helantera I, Aberg F, Lempinen M, et al
    Timing of Organ Procurement From Brain-Dead Donors Associates With Short- and Long-Term Outcomes After Liver Transplantation.
    Transpl Int. 2022;35:10364.
    PubMed     Abstract available

  58. JETTEN WD, Hogenbirk RNM, Van Meeteren NLU, Cuperus FJC, et al
    Physical Effects, Safety and Feasibility of Prehabilitation in Patients Awaiting Orthotopic Liver Transplantation, a Systematic Review.
    Transpl Int. 2022;35:10330.
    PubMed     Abstract available

  59. YAO S, Yagi S, Ogawa E, Hirata M, et al
    Dysbiosis and Depletion of Fecal Organic Acids Correlate With the Severity of Rejection After Rat Liver Transplantation.
    Transpl Int. 2022;35:10728.
    PubMed     Abstract available

  60. CHOTALIA M, Topiwala U, Iqbal A, Parekh D, et al
    Incidence of Gastrointestinal Bleeding After Transesophageal Echocardiography Use in Orthotopic Liver Transplantation.
    Transpl Int. 2022;35:10753.
    PubMed     Abstract available

  61. BEETZ O, Cammann S, Weigle CA, Sieg L, et al
    Interleukin-18 and High-Mobility-Group-Protein B1 are Early and Sensitive Indicators for Cell Damage During Normothermic Machine Perfusion after Prolonged Cold Ischemic Storage of Porcine Liver Grafts.
    Transpl Int. 2022;35:10712.
    PubMed     Abstract available

  62. LAI Q, Lerut J
    A Western World Perspective of Survival Benefit of Living Donor Liver Transplantation: A Commentary to the Article by Jackson et al. Published in JAMA Surgery.
    Transpl Int. 2022;35:10931.

  63. SAFDAR NZ, Hakeem AR, Faulkes R, James F, et al
    Outcomes After Liver Transplantation With Incidental Cholangiocarcinoma.
    Transpl Int. 2022;35:10802.
    PubMed     Abstract available

  64. MINOUX K, Lassailly G, Ningarhari M, Lubret H, et al
    Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation.
    Transpl Int. 2022;35:10569.
    PubMed     Abstract available

  65. MEIER RPH, Kelly Y, Braun H, Maluf D, et al
    Comparison of Biliary Complications Rates After Brain Death, Donation After Circulatory Death, and Living-Donor Liver Transplantation: A Single-Center Cohort Study.
    Transpl Int. 2022;35:10855.
    PubMed     Abstract available

  66. TOMIYAMA T, Harada N, Toshima T, Nakayama Y, et al
    Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study.
    Transpl Int. 2022;35:10723.
    PubMed     Abstract available

  67. FERNANDEZ-CARRILLO C, Li Y, Ventura-Cots M, Argemi J, et al
    Poor Outcomes of Patients With NAFLD and Moderate Renal Dysfunction or Short-Term Dialysis Receiving a Liver Transplant Alone.
    Transpl Int. 2022;35:10443.
    PubMed     Abstract available

  68. TOTI L, Manzia TM, Blasi F, Lenci I, et al
    Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study.
    Transpl Int. 2022;35:10384.
    PubMed     Abstract available

    December 2021
  69. AVOLIO AW, Contegiacomo A, Spoletini G, Moschetta G, et al
    Toward a novel evidence-based definition of early allograft failure in the perspective of liver retransplant.
    Transpl Int. 2021;34:2905-2907.

  70. KARATOPRAK S, Kutlu R, Karatoprak NB, Dag N, et al
    Percutaneous radiological biliary interventions after failed endoscopic treatment in living liver donors: experience of a high-volume transplantation center.
    Transpl Int. 2021;34:2846-2855.
    PubMed     Abstract available

    November 2021
  71. ORCI LA, Combescure C, Fink M, Oldani G, et al
    Predicting recurrence of hepatocellular carcinoma after liver transplantation using a novel model that incorporates tumor and donor-related factors.
    Transpl Int. 2021 Nov 16. doi: 10.1111/tri.14161.
    PubMed     Abstract available

  72. ABERG F, Abrahamsson J, Schult A, Bennet W, et al
    The RETREAT score provides valid predictions regarding hepatocellular carcinoma recurrence after liver transplantation.
    Transpl Int. 2021 Nov 14. doi: 10.1111/tri.14159.
    PubMed     Abstract available

  73. SNEIDERS D, van Dijk ARM, Polak WG, Mirza DF, et al
    Full-left-full-right split liver transplantation for adult recipients: A systematic review and meta-analysis.
    Transpl Int. 2021 Nov 13. doi: 10.1111/tri.14160.
    PubMed     Abstract available

  74. TEO VXY, Heng RRY, Tay PWL, Ng CH, et al
    A Meta-Analysis on the Prevalence of Chronic Kidney Disease in Liver Transplant Candidates and its Associated Risk Factors and Outcomes.
    Transpl Int. 2021 Nov 13. doi: 10.1111/tri.14158.
    PubMed     Abstract available

  75. LIN J, Ko CJ, Lin KH, Hung YJ, et al
    The Glissonian Stitch Traction for Biliary Duct Manipulation in Living Donor Liver Transplantation.
    Transpl Int. 2021 Nov 8. doi: 10.1111/tri.14155.
    PubMed     Abstract available

  76. BHANJI RA, Chow J, Ma M, Pannu N, et al
    Post liver transplantation chronic kidney disease is associated with increased cardiovascular disease risk and poor survival.
    Transpl Int. 2021 Nov 5. doi: 10.1111/tri.14154.
    PubMed     Abstract available

  77. NUTU OA, Sneiders D, Mirza D, Isaac J, et al
    Safety of intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity-score matched survival analysis.
    Transpl Int. 2021 Nov 1. doi: 10.1111/tri.14150.
    PubMed     Abstract available

  78. DUELAND S, Smedman TM, Rosok B, Grut H, et al
    Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases.
    Transpl Int. 2021;34:2205-2213.
    PubMed     Abstract available

  79. YILMAZ S, Akbulut S, Usta S, Ozsay O, et al
    Diagnostic and therapeutic management algorithm for biliary complications in living liver donors.
    Transpl Int. 2021;34:2226-2237.
    PubMed     Abstract available

  80. FANG W, Noda M, Gotoh K, Morooka Y, et al
    Fatty liver disease in living liver donors: a single-institute experience of 220 donors.
    Transpl Int. 2021;34:2238-2246.
    PubMed     Abstract available

  81. WU G, Liu Y, Rui C, Zhan S, et al
    An oxygenated perfluorocarbon emulsion improves liver graft preservation evaluated in DCD livers of male sprague dawley rats.
    Transpl Int. 2021;34:2087-2097.
    PubMed     Abstract available

  82. CAPELLI R, Kitano Y, Linhares M, Da Silva D, et al
    The prognostic significance of serum aspartate transaminase and gamma-glutamyl transferase in liver deceased donors.
    Transpl Int. 2021;34:2247-2256.
    PubMed     Abstract available

    October 2021
  83. LIM SY, Wang R, Tan DJH, Ng CH, et al
    A Meta-Analysis of the Cumulative Incidence, Risk Factors, and Clinical Outcomes associated with Chronic Kidney Disease after Liver Transplantation.
    Transpl Int. 2021 Oct 29. doi: 10.1111/tri.14149.
    PubMed     Abstract available

    September 2021
  84. YUAN Q, Haque O, Yeh H, Markmann JF, et al
    The impact of race and comorbid conditions on adult liver transplant outcomes in obese recipients.
    Transpl Int. 2021 Sep 27. doi: 10.1111/tri.14125.
    PubMed     Abstract available

  85. IVANICS T, Leonard-Murali S, Mouzaihem H, Moonka D, et al
    Extreme Hyponatremia as a Risk Factor for Early Mortality after Liver Transplantation in the MELD-Sodium Era.
    Transpl Int. 2021 Sep 27. doi: 10.1111/tri.14123.
    PubMed     Abstract available

  86. ANDRES A, Sapisochin G, Nadalin S, Adam R, et al
    Liver transplantation for colorectal liver metastasis: aiming for a cure or a palliation?
    Transpl Int. 2021 Sep 7. doi: 10.1111/tri.14032.
    PubMed     Abstract available

  87. BRIGGS G, Wallace D, Flasche S, Walker K, et al
    Inferior outcomes in young adults undergoing liver transplantation - A UK & ireland cohort study.
    Transpl Int. 2021 Sep 6. doi: 10.1111/tri.14033.
    PubMed     Abstract available

  88. CENTONZE L, Di Sandro S, Lauterio A, De Carlis R, et al
    A retrospective single-centre analysis of the oncological impact of LI-RADS classification applied to Metroticket 2.0 calculator in liver transplantation: every nodule matters.
    Transpl Int. 2021;34:1712-1721.
    PubMed     Abstract available

  89. LANARI J, Hagness M, Sartori A, Rosso E, et al
    Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score.
    Transpl Int. 2021;34:1722-1732.
    PubMed     Abstract available

  90. DE STEFANO N, Navarro-Tableros V, Roggio D, Calleri A, et al
    Human liver stem cell-derived extracellular vesicles reduce injury in a model of normothermic machine perfusion of rat livers previously exposed to a prolonged warm ischemia.
    Transpl Int. 2021;34:1607-1617.
    PubMed     Abstract available

    August 2021
  91. BEKKI Y, Von Ahrens D
    The long-term outcomes in liver transplantation using donation after circulatory death grafts.
    Transpl Int. 2021 Aug 21. doi: 10.1111/tri.14023.
    PubMed     Abstract available

  92. TSIEN C, Selzner N
    PSC Recurrence Post Liver Transplantation: Re-Transplantation justified or not?
    Transpl Int. 2021 Aug 19. doi: 10.1111/tri.14014.
    PubMed     Abstract available

  93. GROTTENTHALER JM, Konzelmann A, Stiegler A, Hinterleitner C, et al
    Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation - development of a risk score.
    Transpl Int. 2021 Aug 6. doi: 10.1111/tri.14007.
    PubMed     Abstract available

  94. CABALLERO-MARCOS A, Romero-Cristobal M, Puerto M, Fernandez-Yunquera A, et al
    HCV Eradication in Recurrent Hepatitis C after Liver Transplantation Normalizes Enhanced Endothelial Activation.
    Transpl Int. 2021 Aug 3. doi: 10.1111/tri.14000.
    PubMed     Abstract available

    July 2021
  95. PERETZ D, On NH, Miller D, Kim R, et al
    Pharmacokinetics of a Once Daily Tacrolimus Formulation in First Nations and Caucasian Liver Transplant Recipients.
    Transpl Int. 2021 Jul 28. doi: 10.1111/tri.13997.
    PubMed     Abstract available

  96. NG CH, Lim WH, Lim XC, Xiao J, et al
    A Meta-Analysis on the Incidence of Donor Related Depression after Liver Transplant.
    Transpl Int. 2021 Jul 17. doi: 10.1111/tri.13975.
    PubMed     Abstract available

  97. MCDONALD MF, Barrett SC, Malik TH, Anand A, et al
    Elevated Serum Sodium in Recipients of Liver Transplantation Has a Substantial Impact on Outcomes.
    Transpl Int. 2021 Jul 4. doi: 10.1111/tri.13968.
    PubMed     Abstract available

  98. GROTTENTHALER JM, Fuger JK, Mahling M, Konigsrainer A, et al
    Dynamics of glucose metabolism after liver transplantation: Prediabetes as a window of opportunity for patient survival and long-term kidney function.
    Transpl Int. 2021 Jul 2. doi: 10.1111/tri.13967.
    PubMed     Abstract available

    June 2021
  99. AL-KURD A, Kitajima T, Delvecchio K, Shamaa MT, et al
    Short recipient warm ischemia time improves outcomes in deceased donor liver transplantation.
    Transpl Int. 2021 Jun 25. doi: 10.1111/tri.13962.
    PubMed     Abstract available

  100. EMAMAULLEE J, Conrad C, Kim M, Goldbeck C, et al
    Assessment of the Global Practice of Living Donor Liver Transplantation.
    Transpl Int. 2021 Jun 24. doi: 10.1111/tri.13960.
    PubMed     Abstract available

  101. AMYGDALOS I, Bednarsch J, Meister FA, Erren D, et al
    Clinical value and limitations of the preoperative C-reactive-protein-to-albumin ratio in predicting postoperative morbidity and mortality after deceased-donor liver transplantation: a retrospective single-centre study.
    Transpl Int. 2021 Jun 22. doi: 10.1111/tri.13957.
    PubMed     Abstract available

  102. LAUTERIO A, De Carlis R, Valsecchi M, Vella I, et al
    Liver transplantation during the COVID-19 pandemic: a 2020 year-end report from Lombardy, northern Italy.
    Transpl Int. 2021 Jun 18. doi: 10.1111/tri.13953.
    PubMed     Abstract available

  103. CUSUMANO C, De Carlis L, Centonze L, Lesourd R, et al
    Advanced donor age does not increase risk of hepatocellular carcinoma recurrence after liver transplantation: a retrospective two-center analysis using competing risk analysis.
    Transpl Int. 2021 Jun 18. doi: 10.1111/tri.13950.
    PubMed     Abstract available

  104. HANN A, Sneiders D, Hartog H, Perera MTPR, et al
    Commentary on: Short recipient warm ischemia time improves outcomes in deceased donor liver transplantation.
    Transpl Int. 2021 Jun 18. doi: 10.1111/tri.13949.
    PubMed     Abstract available

  105. CAMPOS-VARELA I, Len O, Villagrasa A, Marquez-Algaba E, et al
    Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort.
    Transpl Int. 2021 Jun 14. doi: 10.1111/tri.13946.
    PubMed     Abstract available

    May 2021
  106. VISSEREN T, Erler NS, Polak WG, Adam R, et al
    Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond.
    Transpl Int. 2021 May 24. doi: 10.1111/tri.13925.
    PubMed     Abstract available

  107. UCHIDA H, Sakamoto S, Kasahara M, Ueno Y, et al
    An analysis of the outcomes in living donor liver transplantation for pediatric malignant hepatic tumors using nationwide survey data in Japan.
    Transpl Int. 2021 May 22. doi: 10.1111/tri.13924.
    PubMed     Abstract available

  108. D'AMICO G, Matsushima H, Diago Uso T, Armanyous SR, et al
    Long Term Outcomes and Complications of Reno-portal Anastomosis in Liver Transplantation: Results from a Propensity Score-Based Outcome Analysis.
    Transpl Int. 2021 May 18. doi: 10.1111/tri.13920.
    PubMed     Abstract available

  109. PASSAMONTI SM, Cannavo A, Panigada M, Trunzo V, et al
    Donation after circulatory death (DCD) and liver transplantation: a cohort study.
    Transpl Int. 2021 May 18. doi: 10.1111/tri.13919.
    PubMed     Abstract available

  110. IVANICS T, Shwaartz C, Claasen MPAW, Patel MS, et al
    Trends in Indications and Outcomes of Liver Transplantation in Canada: A Multi Centre Retrospective Study.
    Transpl Int. 2021 May 11. doi: 10.1111/tri.13903.
    PubMed     Abstract available

  111. NITTA H, Younes A, El-Domiaty N, Karam V, et al
    High Trough Levels of Everolimus Combined to Sorafenib Improve Patients Survival After Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients.
    Transpl Int. 2021 May 1. doi: 10.1111/tri.13897.
    PubMed     Abstract available

  112. LAROCHE S, Maulat C, Kitano Y, Golse N, et al
    Initial piggyback technique facilitates late liver retransplantation - a retrospective monocentric study.
    Transpl Int. 2021;34:835-843.
    PubMed     Abstract available

    April 2021
  113. HO OTW, Ng WCA, Ow ZGW, Ho YJ, et al
    Bisphosphonate Therapy after Liver Transplant Improves Bone Mineral Density and Reduces Fracture Rates: An Updated Systematic-Review and Meta-Analysis.
    Transpl Int. 2021 Apr 21. doi: 10.1111/tri.13887.
    PubMed     Abstract available

  114. KELLY WU W, Ziogas IA, Izzy M, Pai AK, et al
    Liver transplantation for congenital hepatic fibrosis.
    Transpl Int. 2021 Apr 20. doi: 10.1111/tri.13884.
    PubMed     Abstract available

  115. LIM WH, Ng CH, Ow ZGW, Ho OTW, et al
    A Systematic Review and Meta-Analysis on the Incidence of Osteoporosis and Fractures after Liver Transplant.
    Transpl Int. 2021 Apr 9. doi: 10.1111/tri.13863.
    PubMed     Abstract available

  116. LEE SA, Hyun J, Yoon YI, Park SY, et al
    Clinical Impact of Mild to Moderate Pulmonary Hypertension in Living-Donor Liver Transplantation.
    Transpl Int. 2021 Apr 2. doi: 10.1111/tri.13875.
    PubMed     Abstract available

  117. LECLAIRE JM, Smith NJ, Chandratre S, Rein L, et al
    Solid organ donor-recipient race-matching: analysis of the United Network for Organ Sharing database.
    Transpl Int. 2021;34:640-647.
    PubMed     Abstract available

    March 2021
  118. MOLINARI M, Carrillo CF, Dongling D, Jorgensen D, et al
    Portal Vein Thrombosis and Renal Dysfunction: A National Comparative Study of Liver Transplant Recipients for NAFLD versus Alcoholic Cirrhosis.
    Transpl Int. 2021 Mar 29. doi: 10.1111/tri.13873.
    PubMed     Abstract available

  119. OZEN J, Beime J, Brinkert F, Fischer L, et al
    Short- and long-term results of liver transplantation according to age at transplant: a single center experience of 351 children.
    Transpl Int. 2021 Mar 27. doi: 10.1111/tri.13872.
    PubMed     Abstract available

  120. CANTU P, Santi G, Rosa R, Parzanese I, et al
    Cost analysis of a long-term randomized controlled study in biliary duct-to-duct anastomotic stricture after liver transplantation.
    Transpl Int. 2021 Mar 17. doi: 10.1111/tri.13867.
    PubMed     Abstract available

  121. LOZANOVSKI VJ, Probst P, Arefidoust A, Ramouz A, et al
    Prognostic role of the Donor Risk Index, the Eurotransplant Donor Risk Index and the Balance of Risk score on graft loss after liver transplantation.
    Transpl Int. 2021 Mar 16. doi: 10.1111/tri.13861.
    PubMed     Abstract available

  122. YOON YI, Song GW, Lee SG, Park GC, et al
    Safe Use of Right Lobe Living Donor Livers with Moderate Steatosis in Adult-to-adult Living Donor Liver Transplantation: A Retrospective Study.
    Transpl Int. 2021 Mar 4. doi: 10.1111/tri.13859.
    PubMed     Abstract available

  123. MAZZOTTA AD, Pascale A, Cano L, Rosmorduc O, et al
    Number Of HCC Nodules in Patients Listed for Liver Transplantation Within Alpha-Fetoprotein Score : a New Prognostic Risk Factor.
    Transpl Int. 2021 Mar 3. doi: 10.1111/tri.13858.
    PubMed     Abstract available

    February 2021
  124. AKAMATSU N, Hasegawa K, Egawa H, Ohdan H, et al
    Donor age (>/= 45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation - a multicenter retrospective study.
    Transpl Int. 2021 Feb 24. doi: 10.1111/tri.13852.
    PubMed     Abstract available

  125. SASAKI K, Nair A, Firl DJ, McVey JC, et al
    Conditional Probability of Graft Survival in Liver Transplantation using Donation after Circulatory Death grafts - a retrospective study.
    Transpl Int. 2021 Feb 17. doi: 10.1111/tri.13846.
    PubMed     Abstract available

  126. GAMBATO M, Germani G, Perini B, Gringeri E, et al
    A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS-CoV-2 infection.
    Transpl Int. 2021 Feb 8. doi: 10.1111/tri.13842.
    PubMed     Abstract available

  127. ABDELAZIZ O, Osman AMA, Hosny KA, Emad-Eldin S, et al
    Management of Early Hepatic Artery Thrombosis following Living-Donor Liver Transplantation: Feasibility, Efficacy and Potential Risks of Endovascular Therapy in the First 48 Hours Post-Transplant.
    Transpl Int. 2021 Feb 4. doi: 10.1111/tri.13839.
    PubMed     Abstract available

  128. WANIS KN, Sarvet A, Ruffolo LI, Levstik MA, et al
    Estimating the effect of increasing utilization of living donor liver transplantation using observational data.
    Transpl Int. 2021 Feb 1. doi: 10.1111/tri.13835.
    PubMed     Abstract available

    January 2021
  129. SHALABY S, Taborelli M, Zanetto A, Ferrarese A, et al
    Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation.
    Transpl Int. 2021 Jan 25. doi: 10.1111/tri.13831.
    PubMed     Abstract available

  130. CHEN M, Chen Z, Lin X, Hong X, et al
    Application of Ischemia-Free Liver Transplantation Improves Prognosis of Patients with Steatotic Donor Livers.
    Transpl Int. 2021 Jan 23. doi: 10.1111/tri.13828.
    PubMed     Abstract available

  131. LOZANOVSKI VJ, Probst P, Ramouz A, Arefidoust A, et al
    Considering Extended Right Lobe grafts as major Extended Donor Criteria in liver transplantation is justified.
    Transpl Int. 2021 Jan 20. doi: 10.1111/tri.13824.
    PubMed     Abstract available

  132. RICHARDS JA, Randle LV, Butler MChir AJ, Martin JL, et al
    Pilot study of a non-invasive real-time optical backscatter probe in liver transplantation.
    Transpl Int. 2021 Jan 19. doi: 10.1111/tri.13823.
    PubMed     Abstract available

  133. MOURAD M, Lebosse F, Merle P, Levrero M, et al
    External validation of the French AFP model for HCC liver transplantation in a recent unicentric cohort.
    Transpl Int. 2021 Jan 15. doi: 10.1111/tri.13819.
    PubMed     Abstract available

  134. FERRARESE A, Sartori G, Orru G, Frigo AC, et al
    Machine Learning in Liver Transplantation: a tool for some unsolved questions?
    Transpl Int. 2021 Jan 11. doi: 10.1111/tri.13818.
    PubMed     Abstract available

  135. NAGAI S, Safwan M, Kitajima T, Yeddula S, et al
    Disease-Specific Waitlist Outcomes in Liver Transplantation.
    Transpl Int. 2021 Jan 10. doi: 10.1111/tri.13814.
    PubMed     Abstract available

  136. THOMPSON ER, Connelly C, Ali S, Sheerin NS, et al
    Cell therapy during machine perfusion.
    Transpl Int. 2021;34:49-58.
    PubMed     Abstract available

  137. PU X, He D, Liao A, Yang J, et al
    A Novel Strategy for Preventing Posttransplant Large-For-Size Syndrome in Adult Liver Transplant Recipients: A Pilot Study.
    Transpl Int. 2022;35:10177.
    PubMed     Abstract available

  138. ALEXOPOULOS SP, Wu WK, Ziogas IA, Matsuoka LK, et al
    Adult Combined Heart-Liver Transplantation: The United States Experience.
    Transpl Int. 2022;35:10036.
    PubMed     Abstract available

    December 2020
  139. WOO HY, Hong SK, Cho JH, Lee JM, et al
    Complications of Polytetrafluoroethylene Graft-Use in Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation: A Retrospective, Single-Center, Long-Term, Real-World Experience.
    Transpl Int. 2020 Dec 23. doi: 10.1111/tri.13807.
    PubMed     Abstract available

  140. SCHOENBERG MB, Ehmer U, Umgelter A, Bucher JN, et al
    Liver Transplantation versus Watchful-Waiting in Hepatocellular Carcinoma Patients with Complete Response to Bridging-Therapy.
    Transpl Int. 2020 Dec 23. doi: 10.1111/tri.13808.
    PubMed     Abstract available

  141. DI SANDRO S, Magistri P, Bagnardi V, Catellani B, et al
    The Covid-19 second wave risk and liver transplantation: lesson from the recent past and the unavoidable need of living donors.
    Transpl Int. 2020 Dec 18. doi: 10.1111/tri.13803.
    PubMed     Abstract available

  142. MA L, Li M, Zhang T, Xu JQ, et al
    Incidence of de novo autoimmune hepatitis in children and adolescents with increased autoantibodies after liver transplantation: a meta-analysis.
    Transpl Int. 2020 Dec 14. doi: 10.1111/tri.13801.
    PubMed     Abstract available

  143. VAN DEN EYNDE J, Achtergaele J, Fieuws S, Jochmans I, et al
    The effect of organ preservation solutions on short-term outcomes after liver transplantation: a single-centre retrospective study.
    Transpl Int. 2020 Dec 6. doi: 10.1111/tri.13799.
    PubMed     Abstract available

  144. POLAK WG, Fondevila C, Karam V, Adam R, et al
    Reply to Rodriguez-Peralvarez et al.
    Transpl Int. 2020;33:1825-1826.

  145. MANGIONI D, Dondossola D, Antonelli B, Alagna L, et al
    Coronavirus disease 2019 and transplantation: tackling the challenges of SARS-CoV-2 infection in waiting list candidates.
    Transpl Int. 2020;33:1830-1832.

    November 2020
  146. RAUT V, Sonavane A, Shah K, Amruthraj C, et al
    Successful liver transplantation immediately after recovery from COVID-19 in a highly endemic area.
    Transpl Int. 2020 Nov 30. doi: 10.1111/tri.13790.
    PubMed     Abstract available

  147. RHU J, Kim JM, Jeong WK, Choi GS, et al
    Venous outflow congestion is related to poor recurrence-free survival of living donor liver transplantation recipients with hepatocellular carcinoma.
    Transpl Int. 2020 Nov 30. doi: 10.1111/tri.13792.
    PubMed     Abstract available

  148. NAVEZ J, Iesari S, Kourta D, Baami-Mariza K, et al
    The real incidence of biliary tract complications after adult liver transplantation: the role of the prospective routine use of cholangiography during post-transplant follow-up.
    Transpl Int. 2020 Nov 14. doi: 10.1111/tri.13786.
    PubMed     Abstract available

  149. NAM NH, Taura K, Yao S, Kaido T, et al
    Pretransplantation splenomegaly frequently persists after liver transplantation and can manifest as hypersplenism and graft fibrosis - a retrospective study.
    Transpl Int. 2020 Nov 9. doi: 10.1111/tri.13761.
    PubMed     Abstract available

  150. VISSEREN T, Fuhler GM, Erler NS, Nossent YRA, et al
    Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant - a pilot study.
    Transpl Int. 2020;33:1424-1436.
    PubMed     Abstract available

    October 2020
  151. MEMARAN N, Kupper C, Borchert-Morlins B, von Wick A, et al
    Prospective Assessment of Subclinical Cardiovascular Damage and Associated Factors in Liver Transplant Recipients.
    Transpl Int. 2020 Oct 18. doi: 10.1111/tri.13773.
    PubMed     Abstract available

  152. IZZY M, Angirekula M, Bentall A, Plevak M, et al
    Role Of Symmetric Dimethylarginine In Predicting Future Renal Impairment In Liver Transplant Recipients.
    Transpl Int. 2020 Oct 17. doi: 10.1111/tri.13771.
    PubMed     Abstract available

  153. BRUGGENWIRTH IMA, van Reeven M, Vasiliauskaite I, van der Helm D, et al
    Donor diabetes mellitus is a risk factor for diminished outcome after liver transplantation: a nationwide retrospective cohort study.
    Transpl Int. 2020 Oct 17. doi: 10.1111/tri.13770.
    PubMed     Abstract available

  154. PINERO F, Anders M, Boin IF, Chagas A, et al
    Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a multicenter cohort study from a high waitlist mortality region."
    Transpl Int. 2020 Oct 11. doi: 10.1111/tri.13767.
    PubMed     Abstract available

  155. DE CARLIS R, Buscemi V, Checchini G, Frassoni S, et al
    Liver transplantation from brain-dead donors on mechanical circulatory support: a systematic review of the literature.
    Transpl Int. 2020 Oct 9. doi: 10.1111/tri.13766.
    PubMed     Abstract available

  156. MELANDRO F, Ghinolfi D, Balzano E, Tincani G, et al
    Light at the end of the tunnel: COVID-19 lockdown has not halted liver transplantation at a high volume center in Italy.
    Transpl Int. 2020 Oct 8. doi: 10.1111/tri.13764.
    PubMed     Abstract available

  157. KOVANDOVA B, Slavcev A, Honsova E, Erhartova D, et al
    De Novo HLA Class II Antibodies Are Associated with the Development of Chronic but not Acute Antibody-Mediated Rejection after Liver Transplantation.
    Transpl Int. 2020 Oct 5. doi: 10.1111/tri.13763.
    PubMed     Abstract available

  158. BOFFINI M, Pidello S, Simonato E, Barbero C, et al
    An effective protocol for heart transplantation during COVID-19 outbreak.
    Transpl Int. 2020;33:1326-1328.

    September 2020
  159. CHOI D, Liu M, Guttikonda D, Galen K, et al
    Recipient Risk Factors for Acute Cellular Rejection After Orthotopic Liver Transplant.
    Transpl Int. 2020 Sep 29. doi: 10.1111/tri.13756.
    PubMed     Abstract available

  160. PASCALE MM, Bianco G, Ferri L, Agnes S, et al
    COVID-19 health restrictions in a transplanted Italian cohort.
    Transpl Int. 2020;33:1151-1153.

  161. SHI H, Xu J, Li X, Zhao Y, et al
    First organ donation in Wuhan after ending of the coronavirus lockdown.
    Transpl Int. 2020;33:1149-1150.

    October 2019
  162. YAZAWA M, Cseprekal O, Helmick RA, Talwar M, et al
    Association Between Post-Transplant Donor Specific Antibodies and Recipient Outcomes in Simultaneous Liver-Kidney Transplant Recipients: single center, cohort study.
    Transpl Int. 2019 Oct 24. doi: 10.1111/tri.13543.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge.